Teleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual MeetingGlobeNewsWire • 09/09/21
Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 09/01/21
New Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia SymptomsGlobeNewsWire • 08/30/21
Teleflex Incorporated (TFX) CEO Liam Kelly on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/29/21
Largest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift SystemGlobeNewsWire • 07/09/21
Teleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology CongressGlobeNewsWire • 07/06/21
New Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They EnjoyGlobeNewsWire • 06/16/21
Teleflex to Present at the Raymond James 2021 Human Health Innovation ConferenceGlobeNewsWire • 06/07/21
Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS GuidanceGlobeNewsWire • 05/18/21